Rare cancers are more common than you might think. Pancreatic, brain, ovarian, and stomach cancers, plus all cancers affecting children are just a few that fall into the “rare” category. Together, rare cancers account for about half of all cancer cases, yet don’t attract the kind of research funding that more common cancers receive.
Cycle for Survival has hosted life-saving cycling events since 2007, and together with founding partner Equinox, has raised more than $80 million for the Memorial Sloan Kettering Cancer Center with 100 percent of every donation funds rare cancer research. Together with the movement’s founding partner, Equinox, Cycle for Survival has supported innovative clinical trials, research studies, and major research initiatives.
Be sure to check out the MOVE section in the upcoming January 24-26 edition of MRket NYC to see who’s sweating it out on the Cycle for Survival bike (you may even see a few MR editors sweating it out for a cause).
The MRket team will have iPads set up throughout the show that will enable people to make donations on the show floor, or you can donate now to support lifesaving research by clicking here.
Editor’s Note: MR Magazine and MRket trade show are owned by Business Journals Inc.